Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
5-day change
1st Jan Change
18,340
JPY
+0.19%
+5.89%
+4.06%
HOYA : Presentation for the three months ended Sep.30,2018 (with memo)
November 02, 2018 at 05:08 am EDT
FY18Q2
Financial Results
Oct 31, 2018@Station Conference Tokyo
7741.T[ADR:HOCPY US] HOYA CORPORATION
[With Memo]
Please be aware that this memo is posted for reference and is not a verbatim record of all statements made at the meeting.
© 2018 HOYA CORPORATION All Rights Reserved
1. Financial Results [Ryo Hirooka, CFO]
© 2018 HOYA CORPORATION All Rights Reserved
2
Financial Overview
( ¥ bn)
Q2 FY17
Q2 FY18
YoY
YoY(%)
Sales
135.8
142.0
+6.2
+5%
Pretax Profit
32.9
38.4
+5.5
+17%
Net Profit
26.8
31.2
+4.5
+17%
cf. Profit from
ordinary operating
33.5
38.2
+4.7
+14%
activities*
*Herein after "Operating Profit"
Achieved record-high quarterly sales, pretax profit and net profit.
© 2018 HOYA CORPORATION All Rights Reserved
3
Notes RE: Non-Operating Items
Comprehensive Income Statement
( ¥ bn)
Q2 FY17
Q2 FY18
YoY
2
Total Revenue Expenditure
136.4 103.6
143.8 105.4
+7.4 +1.8
Pretax Profit
32.9
38.4
+5.5
Total Revenue increased in excess of sales. This was mainly due to increase in other income ( ¥ 0.8bn) from the sale of a business division.
Essentially zero losses on valuation of assets denominated in foreign currencies last year; foreign exchange loss of ¥0.8bn this year.
© 2018 HOYA CORPORATION All Rights Reserved
5
Attachments
Original document
Permalink
Disclaimer
Hoya Corporation published this content on 02 November 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 02 November 2018 09:07:12 UTC
Japanese Shares Lead Asia Rally, Take Cue from Wall Street
Apr. 24
MT
Hoya Restores Most of Production, Ordering Systems After IT System Failure
Apr. 23
MT
Hoya Flags IT System Failure; Stock Falls 3%
Apr. 04
MT
Japanese lens maker Hoya halts production after cyberattack
Apr. 04
RE
Japan to Extend Subsidy of up to 150 Billion Yen to Kioxia Holdings, Western Digital Plants
Feb. 06
MT
UK Oil & Gas Says Pinarova-1 Project Lacks Commercial Hydrocarbon Flow, Ends Testing Activities
Feb. 02
MT
UK Oil & Gas shares sink after Pinarova-1 testing setback
Feb. 02
AN
UK Oil & Gas notes Pinarova-1 progress in Turkey
Jan. 11
AN
UK Oil & Gas jumps as recommences operations at Pinarova-1
Jan. 03
AN
88 Energy expands Texas footprint with acquisitions
Dec. 15
AN
Vivid Seats Says Secondary Stock Offering Has Closed, Buys Back 2 Million Shares
Dec. 13
MT
HOYA Corporation acquired the remaining 49% stake in Wassenburg Medical B.V.
Nov. 21
CI
Poolbeg hails approval; EDX links with Thermo Fisher
Nov. 21
AN
UK Oil & Gas to Resume Testing at Pinarova JV in Turkey After Receiving Perforating Guns
Nov. 21
MT
Hoya Corporation Announces Interim Dividend for the Six Months Ended September 30, 2023
23-10-31
CI
Hoya Corp. ends 50 Billion Yen Buy-Back Program; Shares Fall Over 3%
23-10-26
MT
Tranche Update on HOYA Corporation's Equity Buyback Plan announced on July 31, 2023.
23-10-25
CI
China Outlook, Global Tensions Churn Asian Stock Markets
23-10-24
MT
HOYA Corporation's Equity Buyback announced on July 31, 2023 has closed with 3,129,800 shares, representing 0.89% for ¥49,999.26 million.
23-10-19
CI
UK Oil & Gas notes resumption of testing at Pinarova-1
23-10-13
AN
UK Oil & Gas to Resume Testing Operations at Turkey Site in Four Weeks
23-10-13
MT
Tranche Update on HOYA Corporation's Equity Buyback Plan announced on July 31, 2023.
23-10-02
CI
UK Oil & Gas Sources New Equipment to Resume Testing at Turkey Site
23-09-22
MT
Japan's Nikkei rises to more than 2-week high, chip stocks shine
23-08-29
RE
Hoya Corporation Announces Establishment of Subsidiary
23-08-29
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Hoya Corporation specialises in the manufacture and commercialisation of optical products. Net sales break down by business segment as follows:
- health (66%): manufacturing of health care products (75.4% of sales; eyeglass lenses and contact lenses) and medical products (24.6%; endoscopes, medical accessories, intraocular lenses, artificial bones and metal implants for orthopedics);
- information technology (33.1%): manufacturing of electronic products (78.2% of sales; photomasks for semiconductors, masks and devices for LCD screens and hard disks) and imaging products (21.8%; optical lenses, optical glasses and laser equipment);
- other (0.9%).
Net sales are distributed geographically as follows: Japan (28.9%), China (8.2%), Asia (24.7%), Europe (19.3%), the United States (15.1%), the Americas (2.4%) and others (1.4%).
More about the company
Last Close Price
18,340
JPY
Average target price
20,882
JPY
Spread / Average Target
+13.86%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1